Hansa Biopharma — Major Shareholding Notification 2017

Aug 9, 2017

Issuer Hansa Biopharma AB

Holder

Gladiator

Instrument

Instrument	aktie SE0002148817
Before the transaction
Shares	1,759,383
Voting rights	1,759,383
Transaction
Reason for major shareholding notification Sell
Date	04/08/2017
Limit for number of shares	5 %
Limit for number of votes	5 %
After the transaction
Quantity
Shares	1,712,383
Directly held voting rights 1,712,383
Indirectly held voting rights	0
Percentage
Directly held shares	4.88487 %
Directly held voting rights	4.88487 %
Indirectly held voting rights	0 %

Resulting distribution of total holdings

		Percentage of voting rights:	Number of underlying shares:
Shares		4.88487 %	1,712,383
	Instruments - FITA Ch. 4, section 2, first paragraph, line 2
	Instruments - FITA Ch. 4, section 2, first paragraph, line 3
	- Physically settled
	- Cash settled
Total		4.88487 %	1,712,383
	Group total holdings
Voting rights	1,712,383
	Percentage of voting rights 4.88486
	Notes (other relevant informations according to law)
	Avser aktier som specialfonden Gladiator har avyttrat
Published
	09/08/2017 12:40
Contact
Name	Max Mitteregger
Phone	0854504841	Email max.mitteregger@mittkap.se

rapportering@fi.se Tfn 08-408 980 37 Fax 08-24 39 25